Key facts
- Notable investors include 500 Global, StartX (US), Astana Hub, Jas Ventures (VC).
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Rette AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Rette AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rette AI
Developer of an artificial intelligence-powered revenue cycle management platform designed for reducing denials and recovering revenue in small specialty practices. The company's platform offers intelligent automation with features such as medical coding, claim scrubbing, prior authorization, and denial management by delivering healthcare-grade security, compliance, and easy integration, enabling clinicians and practice staff to improve efficiency, accelerate cash flow, and minimize administrative burdens.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 2025
- Employees
- 14
- Website
- rette.ai/
- Ownership
- Privately Held (backing)
Rette AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rette AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rette AI in its N-PORT filings yet. We sweep new filings monthly.